The regulatory function of PRMT1 on EGFR would be inhibited by the genetic and pharmacological inhibition of PRMT1, indicating that PRMT1 may be an attractive therapeutic target for PF in the future. The gene discussed is PRMT1; the disease is pemphigus foliaceus.